Latest Shareholder Vote News

Burgundy Diamond Mines has disclosed a breach of ASX Listing Rule 10.1 related to $24.9 million in short-term financing involving related-party diamond sales. The company has halted these sales pending regulatory review and plans to seek shareholder approval.

Capricorn Metals has increased its offer to acquire Warriedar Resources, raising the share exchange ratio and securing unanimous board support. The revised terms enhance value for Warriedar shareholders ahead of upcoming votes.

The ASX has granted key waivers to Predictive Discovery Limited, allowing it to proceed with its merger with Robex Resources Inc without the usual shareholder approvals, streamlining the transaction under Quebec law.

The Takeovers Panel has declined to investigate allegations against Duxton Farms’ major shareholders regarding a complex merger and share placement, clearing the way for the company’s strategic consolidation plans.

The Takeovers Panel has declined to investigate allegations against Duxton Farms’ major shareholders concerning a recent merger and capital placement, affirming no change in control despite reduced voting power.

Mont Royal Resources has lodged a Replacement Prospectus updating its financial disclosures and use of funds ahead of a pivotal shareholder meeting on 10 October to approve a merger with Commerce Resources.

Invex Therapeutics has ended negotiations on two neurological asset acquisitions following due diligence setbacks and shareholder disputes, while advancing R&D collaborations and managing financial stability.

TPG Telecom launches an innovative handset receivables financing structure expected to free up $600 million in cash flow for FY25 and plans a $3 billion capital reduction with a reinvestment plan for minority shareholders.

Memphasys Limited has announced a pro-rata entitlement offer to raise approximately $1.12 million, issuing new shares at $0.003 each with free attaching options, aiming to fund the commercialisation of its Felix™ system and strengthen working capital.

CONNEQT Health has raised $2 million through a convertible note facility with a director-owned entity, providing fresh capital to support its growth plans. Shareholder approval will be key to unlocking the full benefits of this funding.

Platinum Capital Limited’s extraordinary general meeting on 1 October 2025 saw shareholders appoint three L1 Capital nominees to the board while rejecting Wilson Asset Management’s candidates, setting the stage for a potential change in investment management.

Anteris Technologies has gained shareholder approval for an ASX waiver allowing flexible capital raising and updated its PARADIGM trial timeline, now set to begin patient enrolment in Q4 2025 after addressing FDA requests.